Standardized Mississippi Protocol Treatment of 190 Patients with HELLP Syndrome: Slowing Disease Progression and Preventing New Major Maternal Morbidity

REFERENCES

• Sibai BM, Ramadan MK, Usta I, Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169:1000–1006.
   PubMed Web of Science ®Google Scholar
• Martin JN Jr, Rinehart BK, May WL, The spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999; 180:1373–1384.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004; 103:981–991.
   PubMed Web of Science ®Google Scholar
• Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: The integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006; 195:914–934.
   PubMed Web of Science ®Google Scholar
• Altman D, Carroli G, Duley L, Magpie Trial Collaboration Group. Do women with pre‐eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomized placebo-controlled trial. Lancet 2002 Jun 1; 359(9321):1877–1890.
   PubMed Web of Science ®Google Scholar
• Martin JN Jr, Thigpen BD, Moore RC, Stroke and severe preeclampsia and eclampsia: A paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105:246–254.
   PubMed Web of Science ®Google Scholar
• Martin JN Jr, Thigpen BD, Rose CH, Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol 2003; 189:830–834.
   PubMed Web of Science ®Google Scholar
• Rehberg JF, Briery CM, Hudson WT, Bofill JA, Martin JN Jr. Thrombotic thrombocytopenic purpura masquerading as hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome in late pregnancy. Obstet Gynecol 2006; 108:817–820.
   PubMed Web of Science ®Google Scholar
• Fonseca JE, Mendez F, Catano C, Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: A double blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 2005; 193:1591–1598.
   PubMed Web of Science ®Google Scholar
• O’Brien JM. Dexamethasone, HELLP syndrome and study design. Am J Obstet Gynecol 2006 Dec; 195(6):e13–e14.
   Google Scholar
• Katz L, de Amorim MM, Figueiroa JN, Pinto e Silva JL. Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: A double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 2008 Mar; 198(3): 283.e1–e8.
   PubMedGoogle Scholar
• Norwitz ER, Bahtiyar MO, Sibai BM. Can postgraduate courses in maternal-fetal medicine change clinical attitude? J Matern Fetal Neonatal Med 2005 Nov; 18(5):311–317.
   PubMed Web of Science ®Google Scholar
• Vigil-deGracia P. Maternal deaths due to eclampsia and HELLP syndrome. Int J Gynecol Obstet 2009; 104:90–94.
   PubMedGoogle Scholar
• Isler CM, Rinehart BK, Terrone DA, Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1999; 181(4):924–928.
   PubMed Web of Science ®Google Scholar
• Yucesoy G, Ozkan S, Bodur H, Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: A seven year experience of a tertiary care center. Arch Gynecol Obstet 2005; 273:43–49.
   PubMedGoogle Scholar
• Demir SC, Evruke C, Ozgunen FT, Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Saudi Med J 2006; 27:1015–1018.
   PubMed Web of Science ®Google Scholar
• Osmanagaoglu MA, Osmanagaoglu S, Ulusoy H, Bozkaya H. Maternal outcome in HELLP syndrome requiring intensive care management in a Turkish hospital. Sao Paulo Med J 2006; 124:85–89.
   PubMedGoogle Scholar
• Cavkaytar S, Ugurlu EN, Karaer A, Tapisiz OL, Danisman N. Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome? Acta Obstet Gynecol 2007; 86:648–651.
   PubMed Web of Science ®Google Scholar
• Gasem T, al Jama FE, Burshaid S, Maternal and fetal outcome of pregnancy complicated by HELLP syndrome. J Mat Fet Neo Med 2009; 22:1140–1143.
   PubMed Web of Science ®Google Scholar
• Owens MY, Martin JN Jr, Keiser SD, Postpartum multiorgan microangiopathic syndrome (PMMS): A recognizable clinical scenario common to multiple uncommon diseases requiring plasma exchange to enable recovery. Am J Perinatology 2010 (submitted for publication).
   PubMedGoogle Scholar
• Venkatesha S, Toporsian M, Lam C, Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006 Jun; 12(6):642–649.
   PubMed Web of Science ®Google Scholar
• Shames BD, Fernandez LA, Sollinger HW, Liver transplantation for HELLP syndrome. Liver Transpl 2005 Feb; 11(2):224–228.
   PubMedGoogle Scholar
• Zarrinpar A, Farmer DG, Ghobrial RM, Liver transplantation for HELLP syndrome. Am Surg 2007 Oct; 73(10):1013–1016.
   PubMedGoogle Scholar
• O’Brien JM, Milligan DA, Barton JR. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 2000; 183:921–924.
   PubMed Web of Science ®Google Scholar